Literature DB >> 22580283

cGMP-dependent protein kinase I promotes cell apoptosis through hyperactivation of death-associated protein kinase 2.

Kinuka Isshiki1, Shinya Matsuda, Akihiko Tsuji, Keizo Yuasa.   

Abstract

cGMP-dependent protein kinase-I (cGK-I) induces apoptosis in various cancer cell lines. However, the signaling mechanisms involved remain unknown. Using protein microarray technology, we identified a novel cGK substrate, death-associated protein kinase 2 (DAPK2), which is a Ca(2+)/calmodulin-regulated serine/threonine kinase. cGK-I phosphorylated DAPK2 at Ser(299), Ser(367) and Ser(368). Interestingly, a phospho-mimic mutant, DAPK2 S299D, significantly enhanced its kinase activity in the absence of Ca(2+)/calmodulin, while a S367D/S368D mutant did not. Overexpression of DAPK2 S299D also resulted in a twofold increase in apoptosis of human breast cancer MCF-7 cells as compared with wild-type DAPK2. These results suggest that DAPK2 is one of the targets of cGK-I in apoptosis induction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580283     DOI: 10.1016/j.bbrc.2012.04.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Identification of Novel Death-Associated Protein Kinase 2 Interaction Partners by Proteomic Screening Coupled with Bimolecular Fluorescence Complementation.

Authors:  Barbara Geering; Zina Zokouri; Samuel Hürlemann; Bertran Gerrits; David Ausländer; Adrian Britschgi; Mario P Tschan; Hans-Uwe Simon; Martin Fussenegger
Journal:  Mol Cell Biol       Date:  2015-10-19       Impact factor: 4.272

2.  Increasing cGMP-dependent protein kinase I activity attenuates cisplatin-induced kidney injury through protection of mitochondria function.

Authors:  Hasiyeti Maimaitiyiming; Yanzhang Li; Wenpeng Cui; Xiaopeng Tong; Heather Norman; Xinyu Qi; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-03

3.  14-3-3 proteins inactivate DAPK2 by promoting its dimerization and protecting key regulatory phosphosites.

Authors:  Matej Horvath; Olivia Petrvalska; Petr Herman; Veronika Obsilova; Tomas Obsil
Journal:  Commun Biol       Date:  2021-08-19

4.  Nodes-and-connections RNAi knockdown screening: identification of a signaling molecule network involved in fulvestrant action and breast cancer prognosis.

Authors:  N Miyoshi; B S Wittner; K Shioda; T Hitora; T Ito; S Ramaswamy; K J Isselbacher; D C Sgroi; T Shioda
Journal:  Oncogenesis       Date:  2015-10-19       Impact factor: 7.485

5.  Death-Associated Protein Kinase Activity Is Regulated by Coupled Calcium/Calmodulin Binding to Two Distinct Sites.

Authors:  Bertrand Simon; Anne-Sophie Huart; Koen Temmerman; Juha Vahokoski; Haydyn D T Mertens; Dana Komadina; Jan-Erik Hoffmann; Hayretin Yumerefendi; Dmitri I Svergun; Petri Kursula; Carsten Schultz; Andrew A McCarthy; Darren J Hart; Matthias Wilmanns
Journal:  Structure       Date:  2016-04-28       Impact factor: 5.006

6.  Reversibility of glioma stem cells' phenotypes explains their complex in vitro and in vivo behavior: Discovery of a novel neurosphere-specific enzyme, cGMP-dependent protein kinase 1, using the genomic landscape of human glioma stem cells as a discovery tool.

Authors:  Thomas J Wilson; Daniel B Zamler; Robert Doherty; Maria G Castro; Pedro R Lowenstein
Journal:  Oncotarget       Date:  2016-09-27

7.  Non-canonical activation of DAPK2 by AMPK constitutes a new pathway linking metabolic stress to autophagy.

Authors:  Ruth Shiloh; Yuval Gilad; Yaara Ber; Miriam Eisenstein; Dina Aweida; Shani Bialik; Shenhav Cohen; Adi Kimchi
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

Review 8.  Novel Functions of Death-Associated Protein Kinases through Mitogen-Activated Protein Kinase-Related Signals.

Authors:  Mohamed Elbadawy; Tatsuya Usui; Hideyuki Yamawaki; Kazuaki Sasaki
Journal:  Int J Mol Sci       Date:  2018-10-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.